Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Viatris Hikes Guidance With The Wind On Its Back At Halfway Stage
Low-End Guidance Jumps From $17.2bn To $17.5bn Total For 2021
Aug 11 2021
•
By
Dean Rudge
Several factors led Viatris to raise its guidance for 2021 • Source: Alamy
More from Earnings
More from Business